Eijiro Nakamura

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Proteomic Analysis Identifies Potential Biomarkers of ELOC-Mutated Renal Cell Carcinoma.

Proteomic Analysis Identifies Potential Biomarkers of ELOC-Mutated Renal Cell Carcinoma.

Journal: The American journal of surgical pathology

Published: January 15, 2026

Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan.

Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan.

Journal: International journal of clinical oncology

Published: March 29, 2025

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: December 28, 2024

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 11, 2024

Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma.

Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma.

Journal: Cancers

Published: May 02, 2024

The development of innovative therapeutic drugs targeting hypoxia responses

The development of innovative therapeutic drugs targeting hypoxia responses

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: May 01, 2024

2024 Noto Peninsula Earthquake-elderly evacuees and mental health challenges.

2024 Noto Peninsula Earthquake-elderly evacuees and mental health challenges.

Journal: QJM : monthly journal of the Association of Physicians

Published: April 03, 2024

A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response.

A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response.

Journal: Experimental & molecular medicine

Published: April 01, 2024

Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors.

Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 23, 2024

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Journal: World journal of urology

Published: December 15, 2023

Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer.

Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer.

Journal: International cancer conference journal

Published: August 07, 2023

Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer.

Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer.

Journal: Anticancer research

Published: May 15, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026